Ac-Gln(Trt)-OH

Ac-Gln(Trt)-OH is an N-acetylated glutamine derivative bearing a Trt (trityl) protected side-chain amide, providing a protected, non-nucleophilic side chain during peptide assembly and segment handling. The acetylated N-terminus and Trt group reduce undesired side reactions from the amino and side-chain functionality, making the compound a practical building block for controlled peptide fragment synthesis where glutamine's side-chain reactivity must be masked until the intended deprotection step. This reagent is commonly used in workflows that require glutamine incorporation with minimized scrambling, side-chain participation, or premature coupling events.

1. N-Acetylated Peptide Fragments

Ac-Gln(Trt)-OH is used to prepare glutamine-containing peptide fragments where the N-terminus is intentionally capped as an acetyl group, supporting assembly of peptides that require an Ac-protected N-terminus or that need to match a specific peptide end-group pattern for downstream studies. Peptide synthesis teams and peptide chemistry service providers rely on this type of protected glutamine building block to maintain side-chain amide protection with Trt during coupling and purification, improving reproducibility when assembling longer sequences or sensitive segments.

2. Protected Glutamine Building Block

Ac-Gln(Trt)-OH serves as a protected glutamine amino acid building block for stepwise peptide construction in both solution-phase and fragment condensation strategies, particularly when glutamine's side-chain must remain masked to prevent side reactions during the coupling of neighboring residues. The combination of N-acetylation and Trt protection makes it well-suited for preparing defined peptide intermediates used in structure-activity relationship (SAR) studies, peptide library synthesis, and custom peptide manufacturing where consistent residue identity and controlled deprotection timing are required.

3. Sequence-Defined Research Peptides

Ac-Gln(Trt)-OH is frequently selected by academic and industrial groups developing sequence-defined peptides for chemical biology assays and protein interaction studies, where glutamine residues are incorporated with minimized side-chain interference during synthesis and subsequent processing. By keeping the side-chain amide protected until the appropriate stage, this building block helps maintain the integrity of peptide fragments used for purification, analytical characterization (e.g., LC-MS confirmation of intermediates), and final assembly into target peptides that require accurate glutamine placement and end-group fidelity.

4. Pharmaceutical Intermediate Development

Ac-Gln(Trt)-OH is also used as a glutamine-protected intermediate in the preparation of peptide-like or peptide-derived pharmaceutical intermediates, including advanced building blocks that later undergo deprotection and further functionalization. Process development and scale-up teams value this reagent form because it provides a controlled, protected glutamine unit that can be handled as part of a defined synthetic sequence, supporting reliable intermediate generation for downstream coupling steps in complex manufacturing workflows.

1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

4. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

5. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef